Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot (Phase I-II) Study of Valproic Acid (Depakote) for the Treatment of the Autoimmune Lymphoproliferative Syndrome (ALPS)

NCT00605657 is registered in ClinicalTrials.gov with Koneti Rao as lead sponsor.

NCT NCT00605657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00605657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot (Phase I-II) Study of Valproic Acid (Depakote) for the Treatment of the Autoimmune Lymphoproliferative Syndrome (ALPS)
Lead sponsor
Koneti Rao
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2008
Completion date
September 30, 2011
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alps, hypersplenism, lymphadenopathy